Shanghai, China

Ailian Liu

This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Second Medical University, Other. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ailian Liu. Retrieved from https://idiyas.com/inventor/ailian-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Shanghai Second Medical University
 patent
silverMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ailian Liu - Innovator in Stem Cell Research

Introduction

Ailian Liu is a prominent inventor based in Shanghai, China, known for his groundbreaking work in the field of stem cell research. His innovative contributions have the potential to revolutionize regenerative medicine and therapeutic applications.

Latest Patents

Ailian Liu holds a patent for "Embryonic stem cells derived from human somatic cell—rabbit oocyte NT units." This invention discloses a process for obtaining somatic cell-derived embryonic stem cells, encoded by reprogrammed somatic cell nuclei. The patent outlines a method for nuclear transplantation and the induction of these stem cells into various differentiated cell types.

Career Highlights

Throughout his career, Ailian Liu has been associated with Shanghai Second Medical University, where he has contributed significantly to research and development in the medical field. His work has garnered attention for its innovative approach to stem cell technology.

Collaborations

Ailian Liu has collaborated with notable colleagues, including Huizhen Sheng and Ying Chen, who have contributed to his research endeavors.

Conclusion

Ailian Liu's contributions to stem cell research exemplify the potential of innovative science to address complex medical challenges. His work continues to inspire advancements in regenerative medicine and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…